Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MV088 vs Prolia PK Study in Healthy Adults
NCT04673799Phase 1Unknown
- Start
- Feb 2021
- Primary completion
- Oct 2021
- Modality
- Monoclonal Antibodies
01
Overview
Phase 1, randomised, double-blind trial of MV088 in osteoporosis (2 arms). Primary endpoints: Maximum Observed Plasma Concentration at 126 days and Area Under the Curve from time zero to infinity at 126 days. Status: unknown.
02
Drugs
MV088
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT04673799.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04673799.